Camille M. Le Gall

Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells

Mohammad Rashidian, Jessica R. Ingram, Michael Dougan et al. · The Journal of Experimental Medicine · 2017 · 244 citations · Full text

Anti–CTLA-4 therapy requires an Fc domain for efficacy

Jessica R. Ingram, Olga Blomberg, Mohammad Rashidian et al. · Proceedings of the National Academy of Sciences · 2018 · 141 citations · Full text

Immunology, Immunoediting, Biological Therapy +23

Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma Engineering

Camille M. Le Gall, Johan M. S. van der Schoot, Iván Ramos‐Tomillero et al. · Bioconjugate Chemistry · 2021 · 25 citations · Full text

Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering

Johan M. S. van der Schoot, Felix L. Fennemann, Michael Valente et al. · Science Advances · 2019 · 24 citations · Full text

Engineering, Genetics, Immunology +20

Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion

Camille M. Le Gall, Anna Cammarata, Lukas de Haas et al. · Journal for ImmunoTherapy of Cancer · 2022 · 22 citations · Full text